Artemether + lumefantrine

آرتمتر + لومفانترین

⚠ Unverified

🪱 Antiparasitic Products, Insecticides And RepellentsAntimalarial (artemisinin combination)

Market / country: 🇺🇸 USA

Coartem (US)

🧮 Dose calculator

Malaria (prophylaxis and treatment) · Regimen source: FDA Coartem · 2.2–2.3

  • • Shown as the artemether component (20 mg per tablet). First dose, second dose after 8 h, then twice daily for the next 2 days (6 doses total). Take with food; repeat a dose vomited within 1–2 h. FDA Coartem · 2.2–2.3FDA Coartem · 2.1

Enter age and weight.

🛡️ Safety & information

Contraindications

  • ⛔ Hypersensitivity to artemether or lumefantrine. FDA Coartem · 4
  • ⛔ Coadministration with strong CYP3A4 inducers (rifampin, carbamazepine, phenytoin, St John’s wort). FDA Coartem · 4

Warnings

  • • QT prolongation: avoid with known long QT, hypokalaemia or hypomagnesaemia, and with QT-prolonging drugs. FDA Coartem · 5

Important interactions

  • • Rifampin, carbamazepine, phenytoin and St John’s wort cause loss of efficacy (contraindicated). FDA Coartem · 4

Formulations

  • Artemether 20 mg + lumefantrine 120 mg tablet (scored) — tablet 🇺🇸 USA FDA Coartem · 3

👥 Special populations

  • 🤰 PregnancyUse with caution

    Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Coartem · 8.1

    “Risk Summary Published data from clinical studies and pharmacovigilance data have not established an association with artemether/lumefantrine use during pregnancy and major birth defects, miscarriage, or adverse maternal or fetal outcomes (see Data) .”
  • 🤱 BreastfeedingUse with caution

    Label: use with caution while breastfeeding; see the label text. FDA Coartem · 8.2

    “Risk Summary There are no data on the presence of artemether or lumefantrine in human milk, the effects on the breastfed infant or the effects on milk production.”
  • 👶 ChildrenUse with caution

    The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Coartem · 8.4

    “The safety and effectiveness of Coartem Tablets have been established in pediatric patients aged 2 months and older with a bodyweight of 5 kg and above for the treatment of acute, uncomplicated malaria [see Clinical Studies (14.1)] .”
  • 👴 Older adultsUse with caution

    Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Coartem · 8.5

    “Clinical studies of Coartem Tablets did not include sufficient numbers of subjects aged 65 years and over to determine whether they respond differently from younger subjects.”
  • ⚥ Females & males of reproductive potentialUse with caution

    Label has advice on pregnancy testing, contraception or fertility for females and males. FDA Coartem · 8.3

    “Contraception Use of Coartem may reduce the efficacy of hormonal contraceptives.”

📚 Reference status for this drug

Shows which sources have references recorded for this drug and which do not.

🔗 Similar drugs

Doz is only a support tool and does not replace clinical judgment or official sources. Check every dose against the original source before prescribing. About & disclaimer · Sources

Inspired by the Saphira project; part of the content is taken from it.

Contact and correction requests — Telegram: @cenaav